Whether setting a course or changing strategies in today's biopharma landscape, information overload, quickly obsolete insight, and stakeholder misalignment are industry-wide challenges. As an emerging or seasoned bio-tech company, your ability to consistently meet and exceed stakeholder and investor expectations is always on the line. It's imperative therefore that any strategic decisions require something beyond regular gatherings of your leadership team. Sound decisions require precise, timely and actionable competitive information and insight. This panel explores how integrating traditional life sciences competitive intelligence (CI) methods with innovative technology delivery systems provides an undeniable edge at the strategy table. Learn from the leading-edge life sciences CI veterans alongside industry-side insights leaders and how having a strong CI delivery process can underpin strategic decision-making and set your team up for success with stakeholders and investors.